Bausch & LombBLCO +2.58%77 OCF Margin % is 2.57% as of Mar. 2026, which is 79% below its 10-year median of 12.23. GuruFocus rates BLCO with a GF Score™ of 77/100 and a GF Value™ of $18.29 (Modestly Undervalued). The stock has 10 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Bausch & Lomb ranks better than 50.8% on this metric.
The historical rank and industry rank for Bausch & Lomb's OCF Margin % or its related term are showing as below:
BLCO'
s OCF Margin % Range Over the Past 10 Years
Min: -0.41 Med: 12.23 Max: 23.19
Current: 6.53
During the past 8 years, the highest OCF Margin % of Bausch & Lomb was 23.19%. The lowest was -0.41%. And the median was 12.23%.
BLCO's OCF Margin % is ranked better than 50.8% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs BLCO: 6.53
Bausch & Lomb OCF Margin % Related Terms
Bausch & Lomb OCF Margin % Historical Data
* Premium members only.
The historical data trend for Bausch & Lomb's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Bausch & Lomb's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bausch & Lomb OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bausch & Lomb's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Bausch & Lomb's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bausch & Lomb (BLCO) has a OCF Margin % of 2.57% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bausch & Lomb and its competitors. This is 79% below median its historical median of 12.23. According to the industry distribution chart, Bausch & Lomb ranks #401 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 49.2%.
Is Bausch & Lomb's OCF Margin % too high?
Bausch & Lomb's current OCF Margin % of 2.57% is 79% below median its 10-year median of 12.23. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Bausch & Lomb's value of 2.57% is 56.1% below this industry median. Based on the distribution chart, Bausch & Lomb ranks #401 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Bausch & Lomb has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bausch & Lomb's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bausch & Lomb ranks #401 out of 815 companies for OCF Margin %. This puts Bausch & Lomb in the upper half of its industry. The industry median OCF Margin % is 5.86. Bausch & Lomb's value of 2.57% is 56.1% below this benchmark. While the company's 10-year median is 12.23 vs. the industry median of 5.86, Bausch & Lomb has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bausch & Lomb's current OCF Margin % of 2.57% is 56.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bausch & Lomb and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bausch & Lomb's current OCF Margin % is 2.57%, which is 79% below median its own 10-year median of 12.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch & Lomb stock overvalued right now?
Based on GuruFocus' analysis, Bausch & Lomb (BLCO) is currently considered Modestly Undervalued. The stock's GF Value™ is $18.29, compared to a current price of $15.91 — trading 13% below its estimated fair value. The current OCF Margin % is 2.57%, which is 79% below median its 10-year median of 12.23 and 56.1% below the Medical Devices & Instruments industry median of 5.86. Bausch & Lomb's overall GF Score™ is 77/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Bausch & Lomb (BLCO), the current OCF Margin % is 2.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bausch & Lomb (BLCO) Overvalued in 2026?
Based on GuruFocus' analysis, Bausch & Lomb stock appears to be undervalued.
The current stock price of $15.91 is trading 13% below its estimated GF Value™ of $18.29.
GuruFocus considers Bausch & Lomb to be Modestly Undervalued.
Key valuation signals for BLCO:
OCF Margin %: 2.57% (79% below median its 10-year median of 12.23)
GF Value™: $18.29 vs. price of $15.91 (13% below fair value)
Industry Position: 56.1% below the Medical Devices & Instruments median (#401 of 815)
No single metric tells the full story. See the BLCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
77GF Score
Get the complete analysis for BLCO
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BLCO has been successfully added to your 
